Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>Veru is a clinical-stage biopharmaceutical company focused on cardiometabolic and inflammatory diseases.</li><li>Lead drug enobosarm is a selective androgen receptor modulator (SARM) in Phase 2b for obesity, specifically to preserve muscle while on GP-1s for weight loss.</li><li>Second pipeline drug sabizabulin is a microtubule disruptor being evaluated for inflammation in atherosclerotic cardiovascular (CV) disease</li></ul>

Veru is a clinical-stage biopharmaceutical company focused on cardiometabolic and inflammatory diseases.Lead drug enobosarm is a selective androgen receptor modulator (SARM) in Phase 2b for obesity, specifically to preserve muscle while on GP-1s for weight loss.Second pipeline drug sabizabulin is a microtubule disruptor being evaluated for inflammation in atherosclerotic cardiovascular (CV) disease

VERU: Importance of Preserving Muscle in Weight Loss with GLP-1 Obesity Drugs